Targeting ß2 adrenergic receptors regulate human T cell function directly and indirectly

Brain, Behavior, and Immunity

Volumn 45, Issue , 2015, Pages 211-218

  Zalli, A ^a,c   Bosch, J A ^b   Goodyear, O ^a   Riddell, N ^a   McGettrick, H M ^a   Moss, P ^a   Wallace, G R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adrenergic agonists; Catecholamines; Immune function; Lymphocytosis; Sympathetic nervous system

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; SALMETEROL; STAPHYLOCOCCUS ENTEROTOXIN B; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; MATRIX PROTEIN; PHOSPHOPROTEIN; SALBUTAMOL;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BETA ADRENERGIC STIMULATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL KILLING; CELL LYSATE; CHO CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; K562 CELL LINE; MALE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE ACTIVATION; TARGET CELL; UPREGULATION; VIRUS STRAIN; ANALOGS AND DERIVATIVES; ANIMAL; CRICETULUS; DRUG EFFECTS; IMMUNOLOGY; SECRETION (PROCESS); T LYMPHOCYTE;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; ANTIGEN-PRESENTING CELLS; CHO CELLS; CRICETULUS; CYTOMEGALOVIRUS; ENTEROTOXINS; EPINEPHRINE; HUMANS; INTERFERON-GAMMA; K562 CELLS; KILLER CELLS, NATURAL; PHOSPHOPROTEINS; RECEPTORS, ADRENERGIC, BETA-2; T-LYMPHOCYTES; VIRAL MATRIX PROTEINS;

EID: 84924123119     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.12.001     Document Type: Article

References (36)

1. Anane L.H., Edwards K.M., Burns V.E., Drayson M.T., Riddell N.E., van Zanten J.J., Wallace G.R., Mills P.J., Bosch J.A. Mobilization of gammadelta T lymphocytes in response to psychological stress, exercise, and beta- agonist infusion. Brain Behav. Immun. 2009, 23(6):823-829.
2. Andersson U., Tracey K.J. Neural reflexes in inflammation and immunity. J. Exp. Med. 2012, 209(6):1057-1068.
3. Benschop R.J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav. Immun. 1996, 10(2):77-91.
4. Betz M., Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 1991, 146(1):108-113.
5. Bosch J.A., Berntson G.G., Cacioppo J.T., Dhabhar F.S., Marucha P.T. Acute stress evokes selective mobilization of T cells that differ in chemokine receptor expression: a potential pathway linking immunologic reactivity to cardiovascular disease. Brain Behav. Immun. 2003, 17(4):251-259.
6. + T lymphocytes exhibiting an effector-memory phenotype. Brain Behav. Immun. 2009, 23(6):767-775.
7. Dhabhar F.S., Malarkey W.B., Neri E., McEwen B.S. Stress-induced redistribution of immune cells - from barracks to boulevards to battlefields: a tale of three hormones - Curt Richter Award winner. Psychoneuroendocrinology 2012, 37(9):1345-1368.
8. Dimitrov S., Lange T., Born J. Selective mobilization of cytotoxic leukocytes by epinephrine. J. Immunol. 2010, 184(1):503-511.
9. Elenkov I.J., Kvetnansky R., Hashiramoto A., Bakalov V.K., Link A.A., Zachman K., Crane M., Jezova D., Rovensky J., Dimitrov M.A., Gold P.W., Bonini S., Fleisher T., Chrousos G.P., Wilder R.L. Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans?. J. Immunol. 2008, 181(3):1737-1745.
10. + T cell control of latent herpes simplex virus type 1 infections. J. Immunol. 2007, 179(1):322-328.
11. Gotovac K., Vidovic A., Vukusic H., Krcmar T., Sabioncello A., Rabatic S., Dekaris D. Natural killer cell cytotoxicity and lymphocyte perforin expression in veterans with posttraumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34(4):597-604.
12. Goyarts E., Matsui M., Mammone T., Bender A.M., Wagner J.A., Maes D., Granstein R.D. Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp. Dermatol. 2008, 17(3):188-196.
13. + T cell responses. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(13):5300-5305.
14. Herve J., Dubreil L., Tardif V., Terme M., Pogu S., Anegon I., Rozec B., Gauthier C., Bach J.M., Blancou P. Beta2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells. J. Immunol. 2013, 190(7):3163-3171.
15. + T cells: the potential involvement of interleukin-7 in this process. Immunology 2011, 132(3):326-339.
16. Lokshin A., Raskovalova T., Huang X., Zacharia L.C., Jackson E.K., Gorelik E. Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells. Cancer Res. 2006, 66(15):7758-7765.
17. Loza M.J., Foster S., Peters S.P., Penn R.B. Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood 2006, 107(5):2052-2060.
18. Nials A.T., Coleman R.A., Johnson M., Magnussen H., Rabe K.F., Vardey C.J. Effects of beta-adrenoceptor agonists in human bronchial smooth muscle. Br. J. Pharmacol. 1993, 110(3):1112-1116.
19. Nials A.T., Sumner M.J., Johnson M., Coleman R.A. Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol. Br. J. Pharmacol. 1993, 108(2):507-515.
20. Orr M.T., Murphy W.J., Lanier L.L. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 2010, 11(4):321-327.
21. Platzer C., Docke W., Volk H., Prosch S. Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J. Neuroimmunol. 2000, 105(1):31-38.
22. Raskovalova T., Lokshin A., Huang X., Su Y., Mandic M., Zarour H.M., Jackson E.K., Gorelik E. Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling. Cancer Res. 2007, 67(12):5949-5956.
23. Sanders V.M., Straub R.H. Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav. Immun. 2002, 16(4):290-332.
24. Sanders V.M. The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet?. Brain Behav. Immun. 2012, 26(2):195-200.
25. Sanders V.M., Baker R.A., Ramer-Quinn D.S., Kasprowicz D.J., Fuchs B.A., Street N.E. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 1997, 158(9):4200-4210.
26. Shibata M., Endo S., Inada K., Kuriki S., Harada M., Takino T., Sato N., Arakawa N., Suzuki T., Aoki H., Suzuki T., Hiramori K. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J. Interferon Cytokine Res. 1997, 17(3):145-150.
27. Simpson R.J., Florida-James G.D., Cosgrove C., Whyte G.P., Macrae S., Pircher H., Guy K. High-intensity exercise elicits the mobilization of senescent T lymphocytes into the peripheral blood compartment in human subjects. J. Appl. Physiol. 2007, 103(1):396-401. (1985).
28. Snijdewint F.G., Kalinski P., Wierenga E.A., Bos J.D., Kapsenberg M.L. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 1993, 150(12):5321-5329.
29. Takayanagi Y., Osawa S., Ikuma M., Takagaki K., Zhang J., Hamaya Y., Yamada T., Sugimoto M., Furuta T., Miyajima H., Sugimoto K. Norepinephrine suppresses IFN-gamma and TNF-alpha production by murine intestinal intraepithelial lymphocytes via the beta(1) adrenoceptor. J. Neuroimmunol. 2012, 245(1-2):66-74.
30. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 1996, 97(3):713-719.
31. Wahle M., Neumann R.P., Moritz F., Krause A., Buttgereit F., Baerwald C.G. Beta2-adrenergic receptors mediate the differential effects of catecholamines on cytokine production of PBMC. J. Interferon Cytokine Res. 2005, 25(7):384-394.
32. + T cells limits their effectiveness during sustained high viral load. Immunity 2011, 35(2):285-298.
33. Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schoning B., Glockner F., Lanksch W.R., Volk H.D., Docke W.D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 1998, 4(7):808-813.
34. Yang J.H., Lee S.O., Kim S.E., Suh Y.H., Chong Y.H. Norepinephrine differentially modulates the innate inflammatory response provoked by amyloid-B peptide via action at beta-adrenoreceptors and activation of cAMP/PKA pathway in human THP-1 macrophages. Exp. Neurol. 2012, 236(2):199-206.
35. Yokoyama W.M. HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(9):4791-4794.
36. Younes S.A., Punkosdy G., Caucheteux S., Chen T., Grossman Z., Paul W.E. Memory phenotype CD4 T cells undergoing rapid, nonburst-like, cytokine-driven proliferation can be distinguished from antigen-experienced memory cells. PLoS Biol. 2011, 9(10):e1001171.